← Open Payments lookup

LINDA SHEPPARD-REECE: Open Payments

NPI 1023495538 · PEMBROKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$489 in 27 payments from 9 companies in 2025. Trend: 2023 $112 · 2024 $160 · 2025 $489

Food & beverage: $489
CompanyPaymentsAmount
ABBVIE INC.10$135
Otsuka America Pharmaceutical, Inc.4$92
Alkermes, Inc.4$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Vanda Pharmaceuticals Inc.2$37
Teva Pharmaceuticals USA, Inc.1$25
Neurocrine BioSciences, Inc.1$23
Janssen Pharmaceuticals, Inc1$21
Lundbeck LLC1$15

Products named: VRAYLAR, REXULTI, ARISTADA, CAPLYTA, FANAPT, UZEDY, INGREZZA, INVEGA SUSTENNA.

Industry payments across MA — which companies pay providers there.